Sunitinib Capsule
Generic Name |
Sunitinib |
---|---|
Strength |
25 mg / 50 mg |
Form |
Capsule |
Packaging |
1 x 10 Capsule |
Therapeutic use |
Anti Cancer |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Sunitinib Capsule | 25 mg, 50 mg | Anti Cancer |
Product Description For Sunitinib Capsule
products details and uses
Sunitinib Exporter India, Manufacturer, Wholesaler & Distributor
Sunitinib Capsules are a targeted cancer therapy used in the treatment of advanced renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GIST). This medication works by inhibiting specific tyrosine kinase enzymes that promote cancer cell growth and the formation of blood vessels that supply tumors. By blocking these enzymes, Sunitinib helps shrink tumors and slow disease progression.
-
Manufacturing: GMP-compliant production facilities ensure consistent quality and safety.
-
Exporting: Indian exporters supply Sunitinib Capsules to regulated and semi-regulated markets worldwide, meeting international documentation and compliance requirements.
-
Wholesaling & Distribution: A robust network of authorized wholesalers and distributors ensures timely availability of Sunitinib across hospitals, pharmacies, and cancer treatment centers in India and abroad.
-
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Sunitinib to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.